Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 87-93

  Greiner, Jack V ^a,b   Edwards Swanson, Kimberly ^c   Ingerman, Avner ^d  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNSON AND JOHNSON   (United States)

^d Ora Inc   (United States)

Author keywords

Alcaftadine; Allergic conjunctivitis; Conjunctival allergen challenge

Indexed keywords

ALCAFTADINE; OLOPATADINE; PLACEBO;

ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGY TEST; APPLICATION SITE DRYNESS; APPLICATION SITE PARESTHESIA; APPLICATION SITE PRURITUS; ARTICLE; ASTHENOPIA; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INSTILLATION; DRUG SAFETY; DRUG TOLERABILITY; EYE DISEASE; EYE IRRITATION; FEMALE; HUMAN; INJECTION SITE STINGING; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OCULAR PRURITUS; OUTCOME ASSESSMENT; PHOTOPHOBIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SYMPTOM; VISUAL ACUITY;

EID: 79251574323     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S15379     Document Type: Article

References (10)

1. Abelson MB, Smith L, Chapin M. Ocular allergic disease: Mechanisms, disease sub-types, treatment. Ocul Surf. 2003;1(3):38-60.
2. Abelson MB, Loffler O. Conjunctival allergen challenge: Models in the investigation of ocular allergy. Curr Allergy Asthma Rep. 2003;3(4):363-368.
3. Church MK, McGill JI. Human ocular mast cells. Curr Opin Allergy Clin Immunol. 2002;2(5):419-422.
4. Abelson MB, Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol. 1981;99(2):302-304.
5. 4 receptor in allergic conjunctivitis in mice. Eur J Pharmacol. 2009;608(1-3):71-75.
6. 4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41-53.
7. 4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva. Inflamm Res. 2009;58(6):285-291.
8. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol. 1990;108(1):84-88.
9. Patanol® [Prescribing information]. Fort Worth, TX: Alcon Laboratories, Inc; 2007.
10. Abelson MB, Sangler DL, Epstein AB, et al. Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge. Curr Eye Res. 2007;32(12):1017-1022.